Clinical Trial Update: Pulsta® Transcatheter Pulmonary Valve Korean Multicenter Study [NA]

View source ↗

Summary

The Pulsta Transcatheter Pulmonary Valve Korean Multicenter Study has completed (status: COMPLETED) according to the ClinicalTrials.gov entry.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Defect
• Pulmonary Valve Insufficiency
• Pulmonary Valve Stenosis

Drugs mentioned

• Pulsta Transcatheter Pulmonary Valve

Snippet

Sponsor: Taewoong Medical Co., Ltd. | Conditions: Congenital Heart Defect, Pulmonary Valve; Insufficiency, Congenital | NA | Status: COMPLETED